首页> 外文OA文献 >Editorial Comment for the “Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials”. Thrombocytopenia as an important complication with the use of antithrombotic agents

【2h】

Editorial Comment for the “Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials”. Thrombocytopenia as an important complication with the use of antithrombotic agents

机译：编辑评论对药物和患者群体的糖蛋白IIB / IIIa抑制剂的血小板减少血小阴蛋白抑制剂的编辑评论：29个大型安慰剂随机试验的META分析“。血小板减少症作为使用抗血栓形成剂的重要并发症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Shinichi Goto; Shinya Goto;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Drug-induced thrombocytopenia and thrombosis: evidence from patients receiving an oral glycoprotein IIb/IIIa inhibitor in the Orbofiban in Patients with Unstable coronary Syndromes- (OPUS-TIMI 16) trial. [J] . Scirica BM, Cannon CP, Cooper R, Journal of thrombosis and thrombolysis . 2006,第2期

机译：药物诱发的血小板减少症和血栓形成：奥波非班接受口服糖蛋白IIb / IIIa抑制剂的患者在不稳定冠状动脉综合征（OPUS-TIMI 16）试验中的证据。
2. Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. [J] . De Luca G, Navarese EP, Cassetti E, The American Journal of Cardiology . 2011,第2期

机译：糖蛋白IIb / IIIa抑制剂在接受侵入性策略的高危急性冠脉综合征患者中的随机试验的荟萃分析。
3. The clinical significance of circulating B cells secreting anti-glycoprotein IIb/IIIa antibody and platelet glycoprotein IIb/IIIa in patients with primary immune thrombocytopenia [J] . ChenJ., YangL., ChangL., Hematology. . 2012,第5期

机译：原发性免疫性血小板减少症患者分泌抗糖蛋白IIb / IIIa抗体和血小板糖蛋白IIb / IIIa的循环B细胞的临床意义
4. Glycoprotein IIb/IIIa Inhibitors May Modulate the Clinical Benefit of Radial Access as Compared to Femoral Access in Primary Percutaneous Coronary Intervention: A Meta-Regression and Meta-Analysis of Randomized Trials [O] . Stefano Rigattieri, Ernesto Cristiano, Francesca Giovannelli, 2021

机译：糖蛋白IIB / IIIA抑制剂可以调节径向进入的临床益处与初级经皮冠状动脉介入的股权术语相比：随机试验的荟萃回归和荟萃分析
5. Risk of thrombocytopenia with glycoprotein IIb/IIIa inhibitors across drugs and patient populations: a meta-analysis of 29 large placebo-controlled randomized trials [O] . Jeffrey D. Wessler, Robert P. Giugliano 2015

机译：血小板减少血小阴蛋白血小霉素IIB / IIIa抑制剂的风险患者和患者群体：29个大型安慰剂对照随机试验的META分析

Editorial Comment for the “Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials”. Thrombocytopenia as an important complication with the use of antithrombotic agents

著录项

相似文献

相关主题

期刊订阅